84 related articles for article (PubMed ID: 18362918)
1. Foamy virus vectors come of age.
Williams DA
Mol Ther; 2008 Apr; 16(4):635-6. PubMed ID: 18362918
[No Abstract] [Full Text] [Related]
2. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
Bauer TR; Allen JM; Hai M; Tuschong LM; Khan IF; Olson EM; Adler RL; Burkholder TH; Gu YC; Russell DW; Hickstein DD
Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
[TBL] [Abstract][Full Text] [Related]
3. Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
Bauer TR; Olson EM; Huo Y; Tuschong LM; Allen JM; Li Y; Burkholder TH; Russell DW
Gene Ther; 2011 Jun; 18(6):553-9. PubMed ID: 21228879
[TBL] [Abstract][Full Text] [Related]
4. Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency.
Creevy KE; Bauer TR; Tuschong LM; Embree LJ; Silverstone AM; Bacher JD; Romines C; Garnier J; Thomas ML; Colenda L; Hickstein DD
Vet Immunol Immunopathol; 2003 Oct; 95(3-4):113-21. PubMed ID: 12963272
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.
Hunter MJ; Zhao H; Tuschong LM; Bauer TR; Burkholder TH; Persons DA; Hickstein DD
Hum Gene Ther; 2011 Jun; 22(6):689-96. PubMed ID: 21275758
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of a perfect parasite.
Vassilopoulos G; Rethwilm A
Gene Ther; 2008 Oct; 15(19):1299-1301. PubMed ID: 18802996
[No Abstract] [Full Text] [Related]
8. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency.
Kijas JM; Bauer TR; Gäfvert S; Marklund S; Trowald-Wigh G; Johannisson A; Hedhammar A; Binns M; Juneja RK; Hickstein DD; Andersson L
Genomics; 1999 Oct; 61(1):101-7. PubMed ID: 10512685
[TBL] [Abstract][Full Text] [Related]
9. Canine leukocyte adhesion deficiency colony for investigation of novel hematopoietic therapies.
Creevy KE; Bauer TR; Tuschong LM; Embree LJ; Colenda L; Cogan K; Starost MF; Haskins ME; Hickstein DD
Vet Immunol Immunopathol; 2003 Jul; 94(1-2):11-22. PubMed ID: 12842608
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.
Kuijpers TW; Van Lier RA; Hamann D; de Boer M; Thung LY; Weening RS; Verhoeven AJ; Roos D
J Clin Invest; 1997 Oct; 100(7):1725-33. PubMed ID: 9312170
[TBL] [Abstract][Full Text] [Related]
11. Development of foamy virus vectors.
Vassilopoulos G; Josephson NC; Trobridge G
Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
[No Abstract] [Full Text] [Related]
12. Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.
Smith RH; Bloomer H; Fink D; Keyvanfar K; Nasimuzzaman M; Sancheznieto F; Dutta R; Guenther Bui K; Alvarado LJ; Bauer TR; Hickstein DD; Russell DW; Malik P; van der Loo JCM; Highfill SL; Kuhns DB; Pirooznia M; Larochelle A
Hum Gene Ther; 2022 Dec; 33(23-24):1293-1304. PubMed ID: 36094106
[No Abstract] [Full Text] [Related]
13. Canine neutrophil dysfunction caused by downregulation of beta2-integrin expression without mutation.
Kobayashi S; Sato R; Abe Y; Inanami O; Yasui H; Omoe K; Yasuda J; Hankanga C; Oda S; Sasaki J
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):187-96. PubMed ID: 19297030
[TBL] [Abstract][Full Text] [Related]
14. Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency.
Gu YC; Bauer TR; Sokolic RA; Hai M; Tuschong LM; Burkholder T; Bacher J; Starost MF; Hickstein DD
Bone Marrow Transplant; 2006 Mar; 37(6):607-14. PubMed ID: 16444276
[TBL] [Abstract][Full Text] [Related]
15. Remission of Crohn's disease after cord blood transplantation for leukocyte adhesion deficiency type 1.
Jain S; Gozdziak P; Morgan A; Burt RK
Bone Marrow Transplant; 2013 Jul; 48(7):1006-7. PubMed ID: 23334270
[No Abstract] [Full Text] [Related]
16. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
Nelson EJ; Tuschong LM; Hunter MJ; Bauer TR; Burkholder TH; Hickstein DD
Gene Ther; 2010 May; 17(5):672-7. PubMed ID: 20164857
[TBL] [Abstract][Full Text] [Related]
17. Tracking of specific integrant clones in dogs treated with foamy virus vectors.
Ohmine K; Li Y; Bauer TR; Hickstein DD; Russell DW
Hum Gene Ther; 2011 Feb; 22(2):217-24. PubMed ID: 20738155
[TBL] [Abstract][Full Text] [Related]
18. Progress and prospects: foamy virus vectors enter a new age.
Erlwein O; McClure MO
Gene Ther; 2010 Dec; 17(12):1423-9. PubMed ID: 20631802
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for leukocyte adhesion deficiency.
Bauer TR; Hickstein DD
Curr Opin Mol Ther; 2000 Aug; 2(4):383-8. PubMed ID: 11249768
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte CD11/CD18 integrins: biological and clinical relevance.
Mazzone A; Ricevuti G
Haematologica; 1995; 80(2):161-75. PubMed ID: 7628754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
